Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439048 · ClinicalTrials.gov registry record
Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 82
- Enrollment target
NCT01439048 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 82 participants.
The verdict
NCT01439048 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if changes in specific gene products in the placenta or cord/infant blood affect a baby's birth weight, increase the risk of premature birth, or increase the risk of developing diseases of prematurity. We would also like to characterize whether placental epigenetic changes or placental markers of environmental exposures are associated with premature birth.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2009-06 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01439048
The ClinicalTrials.gov registry entry for NCT01439048 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01439048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01439048 about?
NCT01439048 is a clinical study titled "Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants". The purpose of this study is to determine if changes in specific gene products in the placenta or cord/infant blood affect a baby's birth weight, increase the risk of premature birth, or increase the risk of developing diseases of prematurity. We would also like to characterize whether placental epi...
What is the current status of trial NCT01439048?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2009-06. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT01439048?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.